Join the Alliance for Longevity Initiatives (A4LI) for our second annual D.C. Fly-In, the premier event bringing together leaders, advocates, and innovators from around the globe to advance legislative initiatives that promote a healthier human lifespan.
Kick off our summit by hearing from premier researchers and pioneering biotech companies as they present the latest breakthroughs in longevity-focused drug discovery and cutting-edge technologies. In the afternoon, a curated pitch competition featuring 12 innovative startups will spotlight transformative approaches shaping the future of medicine. Enjoy a complimentary breakfast and lunch, and conclude your day with an open bar and ample networking opportunities.
Delve into the real-world impact of longevity medicine through expert panel discussions, keynote presentations, and case studies exploring its effects on our society, economy, and military preparedness. A full day of thought leadership sessions will include breakfast, lunch, and an evening open bar reception for continued conversations and networking.
Join A4LI and our sponsor companies as we meet with congressional representatives to advance collaborative policy efforts. The day’s schedule will be divided into morning and afternoon sessions, ensuring ample time for strategic discussions and engagement. Midday, we will convene for a congressional briefing to share insights and shape the national dialogue on longevity. After wrapping up official meetings by 4 PM, we’ll gather for a celebratory dinner—an opportunity to reflect on the day’s achievements, foster new partnerships, and strengthen our collective vision for a healthier future.
Partner with A4LI to drive groundbreaking advancements in aging research and healthy lifespan policies. As a sponsor, you’ll gain visibility within a growing community of innovators, policymakers, and advocates committed to shaping a healthier future. Join us in creating impactful change today!
The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) nonprofit organization whose mission is to advance legislation and policies that aim to increase healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.
Dr. Tornatore is the Regional Chief of Neurology for MedStar Health and Chairman and Neurologist-in-Chief in the Department of Neurology at MedStar Georgetown University Hospital. He is also the Executive Director of the Multiple Sclerosis Patient Centered Specialty Practice MedStar Georgetown and Professor and Chairman in the Department of Neurology at Georgetown University Medical Center. Dr. Tornatore received his undergraduate degree in neurobiology from Cornell University and then attended Georgetown University School of Medicine where he received his medical degree. Following a Neurology Residency at Georgetown University Hospital, he was a post-doctoral fellow at the National Institute of Neurologic Disorders and Stroke at the National Institutes of Health. Dr. Tornatore has published extensively in the areas of neuroimmunology, neurovirology and Multiple Sclerosis and is currently involved in over 15 clinical trials for the treatment of Multiple Sclerosis. He has won multiple awards in the areas of medical student teaching, patient care and scholarly research.
Carlo Tanroatore
Dr. Tornatore is the Regional Chief of Neurology for MedStar Health and Chairman and Neurologist-in-Chief in the Department of Neurology at MedStar Georgetown University Hospital. He is also the Executive Director of the Multiple Sclerosis Patient Centered Specialty Practice MedStar Georgetown and Professor and Chairman in the Department of Neurology at Georgetown University Medical Center. Dr. Tornatore received his undergraduate degree in neurobiology from Cornell University and then attended Georgetown University School of Medicine where he received his medical degree. Following a Neurology Residency at Georgetown University Hospital, he was a post-doctoral fellow at the National Institute of Neurologic Disorders and Stroke at the National Institutes of Health. Dr. Tornatore has published extensively in the areas of neuroimmunology, neurovirology and Multiple Sclerosis and is currently involved in over 15 clinical trials for the treatment of Multiple Sclerosis. He has won multiple awards in the areas of medical student teaching, patient care and scholarly research.